Skip to main content

Table 1 Patient’s characteristics

From: Risk factors for renal toxicity after inpatient cisplatin administration

 N of Patients (%)
Sex
 Male106 (58)
 Female78 (42)
Tumor Type
 Head and neck68 (37)
 Genitourinary17 (9,5)
 Gynecological23 (13)
 Pulmonary28 (15)
 Gastrointestinal24 (13)
 Hematological14 (7,5)
 Breast3 (1,5)
 Malignant melanoma3 (1,5)
 Thymoma2 (1)
 Endocrine1 (0,5)
 CNS1 (0,5)
Co morbidity
 Hypertension54 (30)
 Diabetes10 (5)
 Cardiopathy12 (6)
 Vasculopathy19 (10)
 COPD21 (11)
 Alcohol abuse28 (15)
 Liver Cirrhosis4 (2)
Drugs and other agents
 ICM during cisplatin26 (14)
 Metformin5 (3)
 ACE-Inhibitor13 (7)
 NSAID28 (15)
 Aminoglycosides3 (2)
 Glycopeptides2 (1)
 Others antibiotics36 (19)
  1. Legend: CNS central nervous system, COPD Chronic obstructive pulmonary disease, ICM Iodinated contrast media, NSAID Non steroidal anti-inflammatory drug